$CPWR

TETRIDYN SOLUTIONS INC

CIK:0000827099|SEC Filings

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)
Revenue	$ 92,403	$ 846,382	$ 495,920	$ 1,019,419
Direct cost of contracts	308,315	629,827	971,299	758,590
Gross Profit (Loss)	(215,912)	216,555	(475,379)	260,829
Operating Expenses
Salaries and compensation	66,082	218,580	130,997	420,535
Professional fees	159,263	111,645	288,064	194,263
General and administrative	42,598	14,518	77,087	21,023
Total Operating Expenses	267,943	344,743	496,148	635,821
Loss from Operations	(483,855)	(128,188)	(971,527)	(374,992)
Other (Expense) Income
Interest expense, net	(750,618)	(683,801)	(1,489,839)	(1,339,610)
Amortization of debt discount	(13,610)	(13,610)	(27,220)	(27,220)
Change in fair value of derivative liability	(3,965,327)	(93,860,116)	59,289,098	(94,358,520)
Gain on conversion of debt	0	0	0	11,898
Total Other (Expense) Income	(4,729,555)	(94,557,527)	57,772,039	(95,713,452)
Income (Loss) Before Income Taxes	(5,213,410)	(94,685,715)	56,800,512	(96,088,444)
Provision for Income Taxes (See Note 9)	0	0	0	0
Net Income (Loss)	$ (5,213,410)	$ (94,685,715)	$ 56,800,512	$ (96,088,444)
Net Income (Loss) per Common Share Basic	$ (0.02)	$ (0.48)	$ 0.25	$ (0.50)
Net Income (Loss) per Common Share Diluted	$ (0.02)	$ (0.48)	$ (0.00)	$ (0.50)
Weighted Average Number of Common Shares Outstanding Basic	225,637,124	196,186,849	225,637,124	193,605,494
Weighted Average Number of Common Shares Outstanding Diluted	225,637,124	196,186,849	4,871,219,580	193,605,494

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Cash Flows From Operating Activities:
Net income (loss)	$ 56,800,512	$ (96,088,444)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Change in fair value of derivative liability	(59,289,098)	94,358,520
Amortization of debt discount	27,220	27,220
Gain on extinguishment of derivative liability	0	(11,898)
Changes in assets and liabilities:
Accounts receivable	983,704	0
Costs in excess of billings	0	(480,219)
Contract liabilities	(25,851)	0
Accounts payable and accrued expenses	1,113,651	2,128,962
Net Cash Used In Operating Activities	(389,862)	(65,859)
Cash Flows From Financing Activities:
Repayments of advances from related parties	(540)	(540)
Common stock subscribed	0	135,000
Proceeds from sale of convertible notes	0	55,000
Preferred stock subscribed	20,000	0
Net Cash Provided by Financing Activities	19,460	189,460
Net increase (decrease) in cash	(370,402)	123,601
Cash at beginning of period	403,667	16,142
Cash at End of Period	33,265	139,743
Supplemental disclosure of cash flow information
Cash paid for interest expense	248,974	3,781
Cash paid for income taxes	0	0
Supplemental disclosure of non-cash investing and financing activities:
Initial value of derivative liability	0	67,895
Note payable converted to common stock	0	10,000
Accrued interest converted to common stock	0	2,047
Derivative liability extinguished upon conversion of note payable	$ 0	$ 20

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Jun. 30, 2026	Dec. 31, 2025
Current Assets
Cash	$ 33,265	$ 403,667
Accounts receivable	92,404	1,076,108
Prepaid expenses	5,000	5,000
Total Current Assets	130,669	1,484,775
Total Assets	130,669	1,484,775
Current Liabilities
Accounts payable and accrued expense	24,294,095	23,470,504
Accrued compensation	7,291,850	7,001,790
Contract liabilities	0	25,851
Notes payable - related party	2,304,170	2,304,170
Convertible notes payable - related party, net	117,500	117,500
Notes payable	3,633,131	3,633,131
Convertible note payable, net	2,632,445	2,534,665
Advances payable - related party, net	38,268	38,808
Derivative liability	16,399,825	75,688,923
Total Current Liabilities	56,711,284	114,815,342
Convertible notes payable due after one year, net	0	70,560
Total Liabilities	56,711,284	114,885,902
Commitments and contingencies (See Note 7)	0	0
Stockholders' deficit
Common stock, $0.001 par value; 200,000,000 shares authorized, 190,012,124 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively	190,013	190,013
Common and preferred stock subscribed	467,500	447,500
Additional paid-in capital	62,521,759	62,521,759
Accumulated deficit	(119,762,707)	(176,563,219)
Total Stockholders' Deficit	(56,580,615)	(113,401,127)
Total Liabilities and Stockholders' Deficit	130,669	1,484,775
Series B Preferred Stock [Member]
Stockholders' deficit
Preferred stock, value	519	519
Series C Preferred Stock [Member]
Stockholders' deficit
Preferred stock, value	2,300	2,300
Series D Preferred Stock [Member]
Stockholders' deficit
Preferred stock, value	$ 1	$ 1